Analytical Data
-
Gene name
ARGLU1
- Application
-
Alternative Names
ARGL1_HUMAN; ARGLU 1; ARGLU1; DKFZp686O08106; FLJ10154; RP11 297I6.1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NWB6
-
Expression Region
1-273aa
-
AA Sequence
MGRSRSRSSSRSKHTKSSKHNKKRSRSRSRSRDKERVRKRSKSRESKRNRRRESRSRSRSTNTAVSRRERDRERASSPPDRIDIFGRTVSKRSSLDEKQKREEEEKKAEFERQRKIRQQEIEEKLIEEETARRVEELVAKRVEEELEKRKDEIEREVLRRVEEAKRIMEKQLLEELERQRQAELAAQKAREVTLGRLESRDSPWQNFQCWVLPPAQFRKRWNTDYLIPFSSKLNIAAKVNFLAYSEVLTDNLKVGSFYKTYSRILFDLMELAI
-
Molecular Weight
59.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ARGLU1, or Arginine-Glycine-Leucine 1, is a crucial protein implicated in various physiological processes, including cell signaling and regulation of gene expression. Its study has gained prominence due to its association with several pathological conditions, particularly in neurodegenerative diseases and metabolic disorders. Recent research has suggested that mutations in the ARGLU1 gene can lead to significant physiological dysregulation, emphasizing the need for a thorough understanding of its structure and function. The development of recombinant ARGLU1 protein allows researchers to explore its biochemical properties, interactions with other biomolecules, and potential roles in disease mechanisms. This recombinant protein serves as a vital tool for elucidating the functional significance of ARGLU1 in cellular pathways and opens up avenues for potential therapeutic interventions. Furthermore, studying the recombinant protein helps clarify the implications of ARGLU1 in human health, underscoring its importance in clinical research and biotechnology. As the field advances, ARGLU1 continues to be a focal point for investigations aimed at understanding its contributions to cellular homeostasis, disease pathogenesis, and developing novel therapeutic strategies.
